Article
Updates on targeted therapies for acute myeloid leukaemia.
British journal of haematology - 1 Jan 2022
Kayser Sabine, Levis Mark J
Abstract excerpt
In the past few years research in the underlying pathogenic mechanisms of acute myeloid leukaemia (AML) has led to remarkable advances in our understanding of the disease. Cytogenetic and molecular aberrations are the most important factors in determining response to chemotherapy as well as long-...
Topics
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- Clinical Decision-Making
- Combined Modality Therapy
- Disease Management
- Disease Susceptibility
- Drug Resistance
- Genetic Predisposition to Disease
- Humans
- Leukemia, Myeloid, Acute
- Molecular Targeted Therapy
- Mutation
- Prognosis
- Protein Kinase Inhibitors
- Recurrence
- Retreatment
- Treatment Outcome